title: Combination of gene expression and genome copy number alteration has a prognostic value for breast cancer.
abstract: Specific genome copy number alterations, such as deletions and amplifications are an important factor in tumor development and progression, and are also associated with changes in gene expression. By combining analyses of gene expression and genome copy number we identified genes as candidate biomarkers of BC which were validated as prognostic factors of the disease progression. These results suggest that the proposed combined approach may become a valuable method for BC prognosis.
authors.forename: C
authors.initials: C
authors.lastname: Cava
authors.forename: I
authors.initials: I
authors.lastname: Zoppis
authors.forename: G
authors.initials: G
authors.lastname: Mauri
authors.forename: M
authors.initials: M
authors.lastname: Ripamonti
authors.forename: F
authors.initials: F
authors.lastname: Gallivanone
authors.forename: C
authors.initials: C
authors.lastname: Salvatore
authors.forename: M C
authors.initials: MC
authors.lastname: Gilardi
authors.forename: I
authors.initials: I
authors.lastname: Castiglioni
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D005260:Female; D018628:Gene Dosage / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D015894:Genome, Human; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D015203:Reproducibility of Results